Scarica l'app Stockscreener
20.06
8.82%
-1.94
Dopo l'orario di chiusura:
20.30
0.24
+1.20%
Precedente Chiudi:
$22.00
Aprire:
$21.95
Volume 24 ore:
260.18K
Relative Volume:
2.26
Capitalizzazione di mercato:
$1.39B
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-6.87%
1M Prestazione:
-17.35%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$19.87
$22.50
Intervallo di 1 settimana:
$19.87
$22.50
Portata 52W:
$19.87
$27.20
Alamar Biosciences Inc Stock (ALMR) Company Profile
Nome
Alamar Biosciences Inc
Settore
Industria
Telefono
510-626-9888
Indirizzo
47071 BAYSIDE PARKWAY, FREMONT
Compare ALMR vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ALMR
Alamar Biosciences Inc
|
20.06 | 1.52B | 0 | 0 | 0 | 0.00 |
ABT
Abbott Laboratories
|
87.41 | 152.88B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
316.48 | 120.18B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.60 | 100.34B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
57.78 | 84.95B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.78 | 47.91B | 6.30B | 1.07B | 1.09B | 1.8406 |
Alamar Biosciences Inc Borsa (ALMR) Ultime notizie
Number of shareholders of Alamar Biosciences, Inc. – NASDAQ:ALMR - TradingView
Alamar Biosciences, Inc. (ALMR) Net Income (Quarterly) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Cash From Financing (Quarterly) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Total Liabilities - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Cash Equivalents (Quarterly) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Enterprise Value - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Cash From Financing (TTM) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Return On Equity (TTM) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Return On Assets (TTM) - Zacks Investment Research
This Southwest Gas Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga
A Quick Look at Today's Ratings for Alamar Biosciences(ALMR.US), With a Forecast Between $27 to $35 - Moomoo
Stifel Initiates Alamar Biosciences at Buy With $28 Price Target - marketscreener.com
Leerink Initiates Alamar Biosciences at Outperform With $35 Price Target - marketscreener.com
Alamar Biosciences, Inc. (ALMR) Market Cap - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Cash From Operations (TTM) - Zacks Investment Research
Stifel initiates Alamar Biosciences stock with buy rating - Investing.com UK
JPMorgan initiates Alamar Biosciences stock with overweight rating By Investing.com - Investing.com Nigeria
JPMorgan initiates Alamar Biosciences stock with overweight rating - Investing.com India
Stifel initiates Alamar Biosciences stock with buy rating By Investing.com - Investing.com India
Alamar Biosciences, Inc. (ALMR) Gross Margin (TTM) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Total Assets (Quarterly) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Total Long Term Debt (Quarterly) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Revenue (Quarterly) Yoy Growth - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Free Cash Flow (TTM) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Dividend Yield (TTM) - Zacks Investment Research
Alamar Biosciences Revenue Jump And IPO Spotlight Neuro Focus Potential - Sahm
Alamar Biosciences, Inc. (ALMR) Ps Ratio (TTM) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Revenue (TTM) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Net Income (TTM) - Zacks Investment Research
ALMR: Alamar Biosciences, Inc.Price & Consenus Chart - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Free Cash Flow (Quarterly) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Profit Margin (Quarterly) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Price To Cash Flow - Zacks Investment Research
Alamar Biosciences Q1 Loss Widens, Revenue Rises - Moomoo
Alamar Biosciences 1Q Rev $26M >ALMR - Moomoo
Alamar Biosciences, Inc. 1Q 2026: Revenue $26.04M, EPS $(1.74) — 10-Q Summary - TradingView
ALMR SEC FilingsAlamar Biosciences 10-K, 10-Q, 8-K Forms - Stock Titan
Alamar Biosciences Reports First Quarter 2026 Financial Results - The Manila Times
Earnings Flash (ALMR) Alamar Biosciences Posts Q1 Net Loss $1.74 a Share - marketscreener.com
Alamar Biosciences (Nasdaq: ALMR) posts 99% Q1 2026 revenue growth - Stock Titan
Earnings Flash (ALMR) Alamar Biosciences, Inc. Reports Q1 Revenue $26.0M - marketscreener.com
Fresh off a $220M IPO, Alamar expands neuro tests and posts $26M quarter - Stock Titan
Alamar Biosciences (ALMR) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
ALMR Technical Analysis & Stock Price Forecast - Intellectia AI
Proteomics firm Alamar climbs 40% after upsized IPO - MSN
Investors can watch Alamar's BofA Healthcare Conference webcast May 12 - Stock Titan
Alamar Biosciences to Participate in BofA Securities 2026 Healthcare Conference - GlobeNewswire
Alamar Biosciences to present at BofA Securities 2026 Healthcare Conference on May 12 - Pluang
Alamar Biosciences Inc - Reuters
Alamar Biosciences Index Debut And Shelf Filing Reshape Investor Tradeoffs - Sahm
Alamar Biosciences Inc Azioni (ALMR) Dati Finanziari
Non sono disponibili dati finanziari per Alamar Biosciences Inc (ALMR). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.22%
1.41%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):